A Study of Tanespimycin (KOS-953) in Patients With Multiple Myeloma in First Relapse - No Study Results Posted

A Study of Tanespimycin (KOS-953) in Patients With Multiple Myeloma in First Relapse (BMS TIME-1)

This study has been completed.

Study NCT00546780 Information provided by Bristol-Myers Squibb

First Received: October 17, 2007 Last Updated: June 21, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	March 2010
Primary Completion Date:	March 2010 (Final data collection date for primary outcome measure)